If the deal happens, the deal could value GSK’s stake in HUL at Rs 26,580 crore ($3.7 billion), based on HUL’s December 13 closing price of Rs 2,005.30 per share, or an about 17 percent appreciation over its pre-merger price
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment